about the author

Josh Sullivan

josh@endpointsnews.com

author articles

A ge­net­ics test­ing out­fit is bail­ing on its CRO ser­vices, choos­ing in­stead to re­fo­cus around pre­ci­sion drugs

4 years ago
Deals
Outsourcing

Covid-19 roundup: Mod­er­na inks fill-fin­ish pact with Sam­sung Bi­o­log­ics; So­ri­ot dis­cuss­es vac­cine woes, says shot 'has ...

4 years ago
Coronavirus

Months af­ter burst­ing in­to the bis­pe­cif­ic scene out of nowhere, Janux fol­lows the Mer­ck hype to an IPO

4 years ago
Financing

Covid-19 roundup: Mod­er­na's jab gains ap­proval in Japan and South Ko­rea; J&J and Gavi reach agree­ment for 200M more ...

4 years ago
Coronavirus

Re­silience has caught the eye of the Cana­di­an gov­ern­ment, which will in­vest $163M to boost mR­NA pro­duc­tion

4 years ago
Coronavirus
Manufacturing

Af­ter record-break­ing de­mand for in­jecta­bles, BD to ex­pand in Spain with $200M Zaragoza plant

4 years ago
Coronavirus
Manufacturing

No­var­tis' San­doz reshuf­fles an­tibi­ot­ic sup­ply chain in EU as field faces a short­age of in­vest­ment

4 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing re­port: Ire­land will pro­duce mR­NA com­po­nent for Pfiz­er's vac­cine; Lon­za re­cruits fed­er­al ...

4 years ago
Coronavirus
Manufacturing

House com­mit­tee grills Emer­gent CEO Bob Kramer over J&J vac­cine de­ba­cle, ill-timed stock sale

4 years ago
People
R&D

Idera of­fi­cial­ly puts to rest its Phase III tri­al in ad­vanced melanoma; BeiGene nabs pri­or­i­ty re­view for sN­DA

4 years ago
News Briefing

Ther­mo Fish­er part­ners with UCSF to pro­vide a one-stop shop for ear­ly biotech man­u­fac­tur­ing

4 years ago
Manufacturing

Covid-19 roundup: US to do­nate 20M more vac­cines over­seas; BerGen­Bio hopes for the best af­ter re­pur­pos­ing flop, ...

4 years ago
Coronavirus

Charles Riv­er keeps adding on to its CD­MO arm, snatch­ing up a vi­ral vec­tor play­er for a tidy $350M

4 years ago
Deals
Manufacturing

Covid-19 roundup: EU to sup­port vac­cine man­u­fac­tur­ing ef­forts in Africa — re­port; Sput­nik Light ap­proved for use in ...

4 years ago
Coronavirus

Gene ther­a­py play­er turned kid­ney spe­cial­ist Ve­ra drops a dud in lead­up to Nas­daq, pric­ing well be­low range

4 years ago
R&D

Vac­cine mak­er North­west Bio claims it's in the home­stretch for its man­u­fac­tur­ing ex­pan­sion in the UK

4 years ago
Manufacturing

Mod­er­na taps in­to Aus­tralia with Covid-19 boost­er deal and the po­ten­tial for lo­cal man­u­fac­tur­ing

4 years ago
Coronavirus
Manufacturing

Re­call re­port: No­vo Nordisk re­calls sam­ples of mul­ti­ple in­sulin prod­ucts af­ter stor­age screw-up

4 years ago
FDA+
Manufacturing

In the lat­est chap­ter of Emer­gent saga, CEO Bob Kramer will ad­dress US House sub­com­mit­tee on plant woes

4 years ago
Coronavirus
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Emer­gent starts clean-up ef­fort af­ter dis­as­trous Form 483; Eli Lil­ly ex­pands li­cens­es ...

4 years ago
Coronavirus
Manufacturing

Covid-19 roundup: Pfiz­er CEO Bourla to write book about vac­cine arms race; Chi­nese mR­NA shot set for PhI­II tri­al in ...

4 years ago
Coronavirus

Per­cep­tive Ad­vi­sors, Xon­toge­ny bring the band back and then some with a $515M sec­ond fund sniff­ing out lead com­pounds

4 years ago
Financing

Alex­ion co-founder Stephen Squin­to is back in the game as CEO, this time for a small gene ther­a­py play­er

4 years ago
People
Financing

Ex-Pur­due Phar­ma chief Mark Tim­ney, named in dozens of opi­oid law­suits, nabs an­oth­er biotech CEO gig

4 years ago
People
First page Previous page 22232425262728 Next page Last page
A service from the Financial Times